Lisa Massmanian

Lisa Massmanian has 10 years of work experience in the clinical operations field. Lisa began their career in 2005 as an ABI Coordinator at ArQule. In 2006, they moved to ImmunoGen, Inc. as a Research Associate III. In 2010, they joined AVEO Pharmaceuticals as a Clinical Research Scientist. In 2013, they worked as a Senior Clinical Trial Manager at Merrimack Pharmaceuticals and a Clinical Team Lead at TESARO. In 2015, they were promoted to Director and Head of Clinical Operations at Curis. In 2017, they moved to SQZ Biotechnologies in the same role. In 2018, they were promoted to Sr. Director and Head of Clinical Operations at Homology Medicines, Inc. In 2021, they moved to Aruvant in the same role and in 2022, they joined Cabaletta Bio in the same role.

Lisa Massmanian completed their B.S. in Behavioral Neuroscience from Northeastern University in 2004, and then went on to earn their M.S. in Regulatory Affairs in Drugs, Biologics and Medical Devices from the same university in 2008.